The preferential β(3)-adrenoceptor agonist BRL 37344 increases force via β(1)-/β(2)-adrenoceptors and induces endothelial nitric oxide synthase via β(3)-adrenoceptors in human atrial myocardium

Lignende værker

• Mechanisms of β(3)-adrenoceptor-induced eNOS activation in right atrial and left ventricular human myocardium
  af: Brixius, Klara, et al.
  Udgivet: (2004)
• Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium
  af: Brixius, Klara, et al.
  Udgivet: (2001)
• β(2)-Adrenoceptors and non-β-adrenoceptors mediate effects of BRL37344 and clenbuterol on glucose uptake in soleus muscle: studies using knockout mice
  af: Ngala, Robert A, et al.
  Udgivet: (2009)
• Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and β(2)-adrenoceptor mechanisms
  af: Ngala, R A, et al.
  Udgivet: (2008)
• Biphasic effects of the beta-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle.
  af: Liu, Y. L., et al.
  Udgivet: (1996)